Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Case Briefing
U.S. Attorney Files Drug Counterfeiting Complaint
In a criminal complaint filed December 5 in the U.S. District Court in Kansas City, MO, a Florida man was charged with selling counterfeit Lipitor', a prescription drug manufactured and distributed by Pfizer Ireland Pharmaceuticals and Pfizer Inc. The complaint alleges that Julio Cesar Cruz sold 203 bottles of Lipitor 10 mg tablets, with each bottle containing 5000 tablets, to G&K Pharma LLC, a Florida firm licensed to sell wholesale drugs in Missouri. Some of the tablets in each bottle tested by the Office of Criminal Investigations for the FDA, however, were counterfeit, ie, not manufactured or distributed by Pfizer. Further forensic analysis indicated that the bottles contained a mixture of counterfeit Lipitor and illegally diverted foreign-manufactured Lipitor. The complaint also alleges that Cruz manipulated and falsified the drugs' pedigree.
Why So Many Great Lawyers Stink at Business Development and What Law Firms Are Doing About It
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
Bankruptcy Sales: Finding a Diamond In the Rough
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Corporate Enforcement Policy: One Year Later
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
A Lawyer's System for Active Reading
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
Protecting Innovation in the Cyber World from Patent Trolls
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.